MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
126.34
+0.01
+0.01%
After Hours: 125.52 -0.82 -0.65% 19:18 06/30 EDT
OPEN
125.88
PREV CLOSE
126.33
HIGH
127.27
LOW
124.19
VOLUME
7.41M
TURNOVER
--
52 WEEK HIGH
155.38
52 WEEK LOW
105.01
MARKET CAP
156.86B
P/E (TTM)
17.19
1D
5D
1M
3M
1Y
5Y
1D
Unusually active option classes on open June 30th
TipRanks · 15h ago
Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech
Seeking Alpha · 16h ago
Africa CDC seeks $18 million in urgent support for Ebola drug trials in DRC
Reuters · 17h ago
Gilead (GILD) Moves 3.3% Higher: Will This Strength Last?
NASDAQ · 1d ago
Tempus AI Stock Faces a Make-or-Break Moment After Its Recent Pullback
Barchart · 1d ago
Weekly Report: what happened at GILD last week (0622-0626)?
Weekly Report · 1d ago
Gilead Sciences (GILD) Trodelvy Approval Puts Its Valuation Story Back In Focus
Simply Wall St · 1d ago
How Trodelvy’s New First-Line Breast Cancer Role Could Reframe Gilead Sciences’ (GILD) Investment Narrative
Simply Wall St · 3d ago
More
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. It is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Livdelzi/Lyvdelzi, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, and others. It also sells and distributes authorized generic versions of Epclusa and Harvoni in the United States through its subsidiary, Asegua Therapeutics LLC. It has control on anitocabtagene autoleucel (anito cel), an investigational BCMA-directed CAR T cell therapy for multiple myeloma. The Company also owns an antibody-drug conjugates (ADCs) platform.

Webull offers Gilead Sciences, Inc stock information, including NASDAQ: GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.